September 11, 2024
Our Q2 2024 cancer review delves into significant R&D partnerships, M&As, and ventures reflecting strong activity for the sector. PeptiDream and Novartis expanded their peptide-drug
September 6, 2024
Our Q2 2024 cancer review delves into R&D and licensing partnership activity, investments, IPOs and M&A. In R&D, PeptiDream expanded its peptide-drug conjugate partnership with
August 29, 2024
Our H1 2024 analysis of the cardiovascular sector explores notable M&As, R&D partnerships, and ventures. Johnson & Johnson completed a $13.1 billion acquisition of Shockwave
I’ve been reviewing data on biopharma business trends for 16 years now, and no one does the number crunching better than Chris Dokomajilar at DealForma. I’ve seen the data pressure tested repeatedly, and it is solid. We’re proud to have him contribute regular pieces to Endpoints News.
DealForma is one of the most valuable tools for business leaders in biotech, whether you are focused on partnering or fundraising (equity, VC investments). Chris and team are nimble, responsive and thorough. With their help, we have been well-prepared with data to inform partnering outreach as well as terms and contract negotiations.
Best product in the business!
Life Sciences Advisory
DealForma is an exceptional and intuitive platform with reliable data that has saved us countless hours. The support team is quick to respond, and they go above and beyond to make sure we get what we need whether it is a quick question or a more intensive project.
Flagship Pioneering (previously)
I like DealForma’s comprehensive coverage of the life sciences industry. The intuitive search functions allow me to quickly extract deal benchmarks and other insights, which are useful in helping me evaluate potential opportunities.
AbbVie
The breadth and quality of information in DealForma has saved our team countless hours over other data sources. The focus on customers also sets them apart. Whether it’s a quick question or a custom project, we get the right people to talk to fast.
Top 10 Pharma Company
Previous
Next
